Sonoma Pharmaceuticals, Inc. financial data

Symbol
SNOA on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5445 Conestoga Court, Suite 150, Boulder, CO
State of incorporation
DE
Fiscal year end
March 31
Former names
Oculus Innovative Sciences, Inc. (to 12/2/2016)
Latest financial report
10-Q - Q4 2024 - Feb 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % -7.24%
Quick Ratio 78.4 % -0.19%
Debt-to-equity 161 % +35.8%
Return On Equity -70.3 % +4.52%
Return On Assets -26.9 % +20%
Operating Margin -31.9 % +11.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.62M shares -89.6%
Common Stock, Shares, Outstanding 1.62M shares -88.2%
Entity Public Float 3.8M USD -99.9%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.46M shares +168%
Weighted Average Number of Shares Outstanding, Diluted 1.46M shares +168%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 14M USD +13.5%
Revenue from Contract with Customer, Excluding Assessed Tax 14M USD +13.5%
Research and Development Expense 1.81M USD +43.5%
Operating Income (Loss) -4.46M USD -0.47%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.74M USD +26.9%
Income Tax Expense (Benefit) 10K USD
Net Income (Loss) Attributable to Parent -3.75M USD +26.2%
Earnings Per Share, Basic 5.81 USD/shares +60.4%
Earnings Per Share, Diluted 5.81 USD/shares +60.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.24M USD +118%
Accounts Receivable, after Allowance for Credit Loss, Current 2.41M USD -16.4%
Inventory, Net 3.14M USD +6.36%
Assets, Current 12.4M USD -0.98%
Deferred Income Tax Assets, Net 760K USD -17.6%
Property, Plant and Equipment, Net 215K USD -45.8%
Operating Lease, Right-of-Use Asset 119K USD -65.1%
Other Assets, Noncurrent 73K USD -6.41%
Assets 13.7M USD -6.5%
Accounts Payable, Current 1.4M USD +61.5%
Employee-related Liabilities, Current 1.42M USD -3.01%
Liabilities, Current 3.7M USD +20.5%
Operating Lease, Liability, Noncurrent 29K USD -81.9%
Liabilities 8.8M USD +11%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.55M USD -61.3%
Retained Earnings (Accumulated Deficit) -197M USD -1.94%
Stockholders' Equity Attributable to Parent 4.87M USD -27.2%
Liabilities and Equity 13.7M USD -6.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -912K USD -324%
Net Cash Provided by (Used in) Financing Activities 636K USD
Net Cash Provided by (Used in) Investing Activities -5K USD +70.6%
Common Stock, Shares Authorized 50M shares +108%
Common Stock, Shares, Issued 1.62M shares -88.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -539K USD -95.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.24M USD +118%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD 0%
Deferred Tax Assets, Valuation Allowance 30.8M USD +0.09%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 32.1M USD +0.62%
Operating Lease, Liability 119K USD -65.1%
Payments to Acquire Property, Plant, and Equipment 5K USD -70.6%
Lessee, Operating Lease, Liability, to be Paid 128K USD -66.4%
Property, Plant and Equipment, Gross 2.75M USD +9.71%
Operating Lease, Liability, Current 90K USD -50.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One 65K USD -51.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 90K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9K USD -77.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8K USD -76.5%
Deferred Tax Assets, Operating Loss Carryforwards 28.7M USD +0.47%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 714K shares
Unrecognized Tax Benefits 20K USD -63%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 39K USD -13.3%
Deferred Tax Assets, Net of Valuation Allowance 1.3M USD +15.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares